<p>In a series of investigations in the treatment of acute myocardial infarction, bradycardia and hypotension occurred more commonly, as expected for any beta blocker. In addition, a variety of adverse efects has been reported with other beta-adrenergic blocking agents, and may be considered potential adverse efects of Atenolol.</p>

<ul>
	<li><strong>Hematologic</strong>: Agranulocytosis.</li>
	<li><strong>Allergic</strong>: Fever, combined with aching and sore throat, laryngospasm, and respiratory distress.</li>
	<li><strong>Central Nervous System</strong>: Reversible mental depression progressing to catatonia; an acute reversible syndrome characterized by disorientation of time and place; short term memory loss; emotional lability with slightly clouded sensorium; and, decreased performance on neuropsychometrics.</li>
	<li><strong>Gastrointestinal</strong>: Mesenteric arterial thrombosis, ischemic colitis.</li>
	<li><strong>Miscellaneous</strong>: There have been reports of skin rashes and/or dry eyes associated with the use of beta-adrenergic blocking drugs. Discontinuance of the drug should be considered if any such reaction is not otherwise explicable. Patients should be closely monitored following cessation of therapy.</li>
	<li><strong>Other</strong>: Erythematous rash</li>
</ul>